Form 4: Catalyst Pharmaceuticals Director Molly Harper Sells Shares for Personal Reasons

Director Molly Harper sold 5,333 shares of Catalyst Pharmaceuticals (CPRX) common stock at an average price of $16.304 per share on June 3, 2024, for personal reasons.

Summary

• On June 3, 2024, Molly Harper, a director of Catalyst Pharmaceuticals, sold 5,333 shares of the company's common stock.
• The shares were sold at a weighted average price of $16.304, with individual sales ranging from $16.26 to $16.34 per share.
• The sale was conducted for personal reasons, and Ms. Harper remains a director of the company.

Sentiment

Score: 5

Explanation: Neutral sentiment as the transaction is described as being for personal reasons and the director remains with the company.

Management Comments

• Shares were sold for personal reasons and not as a result of any disagreement with the Company.
• Ms. Harper remains a director of the Company.

Industry Context

Sales of shares by company directors are a normal part of market activity. Investors often look to these sales for insight into a director's perspective on the company's value, though personal reasons are often cited.

Stakeholder Impact

• The sale of shares by a director may cause short-term fluctuations in the stock price, but the stated reason of 'personal reasons' mitigates potential negative interpretations.

Key Dates